Clinical studies showed that the overexpression of IL-6 and Cox-2 contributes significantly to tumor growth [6, 19–21] and blockades of IL-6 and Cox-2 signaling are potential chemotherapies [17, 20–22]. Here, IL6 is linked to neoplasm.